Moderna, Inc. (MRNA) — Stock Score Summary

Moderna, Inc. (MRNA) has a MoatMap StockRank of 54/100 based on Quality (30/100), Value (39/100), and Momentum (71/100) factor scores. The current signal is HOLD. Moderna is a biotech firm with highly volatile earnings and a declining post-pandemic product portfolio. It lacks the stable, high-ROIC recurring revenue stream required by our Terry Smith lens, and is a customer rather than a beneficiary of the CDMO pricing power cycle.

Moderna, Inc. is a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines for infectious diseases, immuno-oncology, and rare diseases. Its pioneering mRNA technology platform, broad pipeline, and demonstrated ability to rapidly develop vaccines constitute its competitive moat. Moderna is a leading innovator in mRNA technology, distinguished by its rapid drug development capabilities and extensive investment in R&D.

Key Financial Metrics

Price$47.73
Market Cap$18.9B
P/E (Forward)-12.27
Price/Book2.76
Return on Equity-36.6%
Return on Invested Capital-26.6%
Debt/Equity17.52
Gross Margin-69.9%
Operating Margin-131.1%
Revenue Growth260.2%
Free Cash Flow$-20M

Moderna, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Moderna, Inc.’s (MRNA) StockRank?
MoatMap’s StockRank for Moderna, Inc. (MRNA) is 54/100, with a Hold signal. It is a composite of Quality (30), Value (39), and Momentum (71) factor ranks across MoatMap’s 19,000+ stock universe.
Does Moderna, Inc. have an economic moat?
Moderna, Inc. (MRNA) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Moderna, Inc. a buy, hold, or sell?
MoatMap’s current signal for Moderna, Inc. (MRNA) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Moderna, Inc. in?
Moderna, Inc. (MRNA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksMRNA deep dive reportAI ChampionsHow we score stocksSense-check another stock